Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 16, 2019

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Critical IllnessAcute Kidney InjurySepsisSystemic Inflammatory Response Syndrome
Interventions
DEVICE

Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT)

Every center will prescribe EBPT with commercial membranes in accordance with local practice and local levels of expertise. No variation in treatment prescription and/or treatment solutions will derive from participation in this prospective observational study. Nonetheless, every setting parameter will be recorded in the web-based registry and analyzed a-posteriori to reveal a potential correlation with the patient outcomes.

Trial Locations (15)

10144

RECRUITING

Ospedale Maria Vittoria, Torino

20089

RECRUITING

Humanitas Research Hospital, Rozzano

20097

RECRUITING

IRCCS Policlinico S. Donato, San Donato Milanese

20900

RECRUITING

Ospedale S. Gerardo, Monza

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

36100

RECRUITING

Ospedale S. Bortolo, Vicenza

50053

RECRUITING

Ospedale S. Giuseppe, Empoli

50100

RECRUITING

Azienda Ospedaliero Universitaria Careggi, Florence

51100

RECRUITING

Ospedale S. Jacopo, Pistoia

55049

RECRUITING

Ospedale Versilia, Lido di Camaiore

59100

RECRUITING

Ospedale S. Stefano, Prato

72100

RECRUITING

Ospedale A. Perrino, Brindisi

89124

RECRUITING

"Grande Ospedale Metropolitano Bianchi Melacrino Morelli", Reggio Calabria

00168

RECRUITING

Policlinico Universitario Fondazione Agostino Gemelli, Roma

00189

RECRUITING

Azienda Ospedaliero-Universitaria Sant'Andrea, Roma

All Listed Sponsors
collaborator

University of Florence

OTHER

lead

Careggi Hospital

OTHER